|Bid||117.17 x 1300|
|Ask||119.34 x 800|
|Day's range||115.30 - 117.29|
|52-week range||100.39 - 149.28|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||84.94|
|Forward dividend & yield||0.96 (0.83%)|
|Ex-dividend date||24 Jun 2022|
|1y target est||N/A|
Despite solid Product revenues, Accuray (ARAY) reports an overall soft Q4 performance.
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.
Masimo's (MASI) robust product shipments and strength in its healthcare business drive its Q2 sales.